Startseite › Multiples Myelom › New Jersey › Edison
Klinische Studien zu Multiples Myelom in Edison, NJ
22 Studien zu Multiples Myelom suchen Teilnehmer an Standorten in und um Edison (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Teilnehmer gesuchtPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi entfernt
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Teilnehmer gesuchtPhase 3
- Astera Cancer Care, East Brunswick · 6 mi entfernt
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Teilnehmer gesuchtPhase 3
- Astera Cancer Care, East Brunswick · 6 mi entfernt
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Teilnehmer gesuchtPhase 3
- MSK Basking Ridge, Basking Ridge · 15 mi entfernt
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Teilnehmer gesuchtPhase 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi entfernt
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Teilnehmer gesuchtPhase 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi entfernt
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Teilnehmer gesuchtPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi entfernt
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Teilnehmer gesuchtPhase 3
- MSK Basking Ridge, Basking Ridge · 15 mi entfernt
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Teilnehmer gesuchtPhase 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi entfernt
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Teilnehmer gesuchtPhase 3
- Research Site, East Brunswick · 6 mi entfernt
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Teilnehmer gesuchtBeobachtungsstudie
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi entfernt
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Teilnehmer gesuchtPhase 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi entfernt
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Teilnehmer gesuchtPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi entfernt
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Teilnehmer gesuchtPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi entfernt
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Teilnehmer gesuchtFrühe Phase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi entfernt
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 3 mi entfernt
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Teilnehmer gesuchtPhase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi entfernt
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Teilnehmer gesuchtPhase 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 3 mi entfernt
A Dietary Study for People With Multiple Myeloma
Teilnehmer gesucht
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi entfernt
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Teilnehmer gesuchtPhase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi entfernt
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Teilnehmer gesuchtPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi entfernt
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi entfernt
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Teilnehmer gesucht
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi entfernt
Multiples Myelom-Studien in anderen Städten
- New York City, NY60 Studien
- Boston, MA42 Studien
- Atlanta, GA41 Studien
- Houston, TX38 Studien
- Durham, NC37 Studien
- Nashville, TN32 Studien
- Denver, CO27 Studien
- Rochester, MN24 Studien
- St. Louis, MO24 Studien
- Columbus, OH24 Studien
- Baldwin Park, CA23 Studien
- Chicago, IL22 Studien
Weitere Studien in Edison
- Brustkrebs68 Studien
- Nichtkleinzelliges Lungenkarzinom47 Studien
- Krebs (alle Arten)33 Studien
- Prostatakrebs29 Studien
- Kolorektales Karzinom23 Studien
- Lungenkrebs23 Studien
- Blasenkrebs21 Studien
- Metastasierender Krebs20 Studien
- Eierstockkrebs20 Studien
- Akute myeloische Leukämie20 Studien
- Endometriumkarzinom19 Studien
- Urothelkarzinom (Transitional Cell Carcinoma)18 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.